Back to top
more

Avita Medical (RCEL)

(Real Time Quote from BATS)

$5.58 USD

5.58
73,090

+0.22 (4.10%)

Updated Aug 7, 2025 12:34 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (84 out of 246)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Avita Medical Inc. (RCEL) Stock Jumps 6.2%: Will It Continue to Soar?

by Zacks Equity Research

Avita Medical Inc. (RCEL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

Wall Street Analysts See a 127% Upside in Avita Medical Inc. (RCEL): Can the Stock Really Move This High?

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 127.1% in Avita Medical Inc. (RCEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Equity Research

Does Avita Medical Inc. (RCEL) Have the Potential to Rally 210% as Wall Street Analysts Expect?

by Zacks Equity Research

The mean of analysts' price targets for Avita Medical Inc. (RCEL) points to a 209.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Equity Research

AVITA Medical, Inc. (RCEL) Soars 8%: Is Further Upside Left in the Stock?

by Zacks Equity Research

AVITA Medical, Inc. (RCEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Equity Research

Acadia Healthcare (ACHC) Starts Building New Behavioral Facility

by Zacks Equity Research

Acadia Healthcare (ACHC) opens a new behavioral facility to tap the growing market of mental illness.

Zacks Equity Research

All You Need to Know About AVITA Medical, Inc. (RCEL) Rating Upgrade to Buy

by Zacks Equity Research

AVITA Medical, Inc. (RCEL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Acadia Healthcare (ACHC) Forms JV to Build Behavioral Health Units

by Zacks Equity Research

Acadia Healthcare (ACHC) enters into a joint venture with Geisinger Health to build twin units for offering access to the much-needed behavioral healthcare all across Pennsylvania.

Zacks Equity Research

Acadia Healthcare (ACHC) Gets Rating Upgrade Post U.K. Unit Sale

by Zacks Equity Research

Acadia Healthcare's (ACHC) numerous ratings get upgraded by Moody's after the divestment of its U.K. operations.

Zacks Equity Research

AVITA Medical (RCEL) is Overbought: Is A Drop Coming?

by Zacks Equity Research

AVITA Medical, Inc. (RCEL) has moved higher as of late, but there could definitely be trouble on the horizon for this company.

Zacks Equity Research

Acadia Healthcare (ACHC) to Sell UK Unit to Focus on US Business

by Zacks Equity Research

Acadia Healthcare (ACHC) to divest its U.K. business to Waterland for concentrating on its mental health business in the United States.

Zacks Equity Research

Acadia Healthcare (ACHC) Up 54% in 6 Months: More Room to Run?

by Zacks Equity Research

Acadia Healthcare (ACHC) gains on the back of rising demand for its behavioral healthcare services, business rejig, cost-controlling efforts and strong cash flows.

Zacks Equity Research

Reasons to Add Acadia Healthcare (ACHC) to Your Portfolio

by Zacks Equity Research

Better-than-expected Q3 results, positive estimate revisions, high demand for services, bed expansion, business streamlining make Acadia Healthcare (ACHC) an attractive investment bet.

Sanghamitra Saha headshot

4 Sector ETFs & Stocks to Buy on Forecast-Beating Jobs Data

by Sanghamitra Saha

The U.S. economy added 1.76 million jobs in July 2020, down from a record 4.8 million in the previous month. However, the reading beat market expectations of a 1.6 million increase.

Zacks Equity Research

Encompass Health to Build Rehabilitation Hospital in Illinois

by Zacks Equity Research

Encompass Health (EHC) plans to build a rehabilitation facility in Illinois to serve the local community. The healthcare home will be launched in 2022 spring and complement other units in the area.

Sapna Bagaria headshot

Hospital Industry's Dull Near-Term Outllook Induced by Coronavirus

by Sapna Bagaria

Revenue loss and cost rise due to coronavirus outbreak put hospital companies in a tight spot.

Zacks Equity Research

Community Health Systems (CYH) in Focus: Stock Moves 5.9% Higher

by Zacks Equity Research

Community Health Systems (CYH) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Sanghamitra Saha headshot

Biotech Rally Sends Nasdaq to 9000: ETFs in Focus

by Sanghamitra Saha

Some biotech stocks have contributed materially to the Nasdaq's 1000-point gain since Aug 27, 2018 and helped it notch a record 9,000 on Dec 26.

Sanghamitra Saha headshot

5 Top-Ranked ADRs That More Than Doubled the S&P 500 in 2019

by Sanghamitra Saha

Though international markets trailed the U.S. market in 2019, there are hidden gems that crushed the S&P 500 this year on stock-specific strength.